New active substance shows promise in treating acute sudden hearing loss

A research team led by MedUni Vienna has investigated AC102, a new active substance that offers hope of an effective treatment for acute sudden hearing loss. The latest results have been published in the scientific journal “Cell Death & Disease”.

New treatment options offer hope for patients with non-small cell lung cancer

More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumour cells, with less need

October 18, 2023

Bicuspid Aortic Valves and Aortopathy Cluster Among Close Relatives

Diagnoses of bicuspid aortic valve (BAV), thoracic aortic aneurysm, and thoracic aortic dissection appeared to run in families extending beyond first-degree relatives, according to the

June 16, 2023

Solera Health Expands HALO Platform to Tackle High-Cost Specialty Care with Virtual Specialists

What You Should Know: – Solera Health, a leading healthcare technology platform, today announced a significant expansion of its HALO Platform. This next-generation solution now

January 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.